| Credential | Full Name | Focus |
|---|---|---|
| CWOCN | Certified Wound, Ostomy and Continence Nurse | All three domains |
| CWON | Certified Wound and Ostomy Nurse | Wound + Ostomy |
| CFCN | Certified Foot Care Nurse | Foot care specialist |
| COCN | Certified Ostomy Care Nurse | Ostomy only |
Credentialing body: Wound, Ostomy and Continence Nursing Certification Board (WOCNCB). All credentials require CE maintenance every 5 years.
- Respond to ward referrals for complex wound/stoma/continence problems
- Run specialist outpatient clinics (wound clinic, stoma clinic, continence clinic)
- Pre-operative stoma marking and patient education
- Discharge planning and home care liaison
- Staff education and training on wound/stoma/continence protocols
- Participation in multidisciplinary team (MDT) meetings
- Product procurement advisory — formulary selection committee
- Clinical trial and product evaluation participation
- Policy and protocol development for institution
- Insurance/DMERC documentation for patients
- Supplier relationship management
- Research and quality improvement projects
GCC has among the world's highest DM prevalence. UAE: ~19%, Saudi Arabia: ~18%, Kuwait: ~23%. This translates to massive demand for diabetic foot ulcer management, offloading, and limb salvage programs.
Rising rates of colorectal cancer, bladder cancer, and Crohn's disease surgery generate stoma patients requiring ET specialist support. Urology surgery volumes drive continence needs.
GCC nationals are aging rapidly. Pressure injuries, venous insufficiency, and urinary incontinence rise sharply with age. Long-term care and home health sectors are expanding to meet this demand.
| Dimension | WOC Specialist Nurse | Bedside/General Nurse |
|---|---|---|
| Scope | Specialist consultant across wards and clinics | Direct care for assigned patient caseload |
| Wound management | Complex wounds, NPWT, fistulas, post-surgical dehiscence | Routine dressing changes per WOC nurse's plan |
| Stoma care | Siting, immediate post-op, complex complications | Pouching changes per established plan |
| Continence | Urodynamics, PTNS, neuromodulation follow-up | Catheter care, continence product use |
| Decision-making | Autonomous specialist assessment and treatment decisions | Protocol-based within physician orders |
| Salary (UAE) | AED 15,000 – 25,000/month | AED 6,000 – 12,000/month |
| Component | Stands For | Goal | Interventions |
|---|---|---|---|
| T | Tissue (non-viable) | Remove necrotic/sloughy tissue | Sharp debridement, autolytic, enzymatic, maggot therapy |
| I | Infection/Inflammation | Control bioburden | Systemic antibiotics, topical antimicrobials (silver/PHMB), biofilm-targeted therapy |
| M | Moisture imbalance | Optimal moisture balance | Absorbent dressings for excess; hydrating dressings for dry wounds |
| E | Edge of wound (non-advancing) | Stimulate epithelialisation | NPWT, growth factors, skin grafting, epibole correction |
Select the status of each TIME component to generate wound bed preparation recommendations and dressing suggestions.
T — Tissue (non-viable tissue present)
I — Infection / Inflammation
M — Moisture Balance
E — Edge of Wound
- Complex surgical wounds / dehiscence
- Diabetic foot ulcers (Wagner grade 2–4)
- Pressure injuries (Stage 3–4)
- Traumatic wounds / degloving
- Skin graft fixation (NPWT over graft)
- Open abdomen / laparostomy
- Burns (partial thickness)
- Malignancy in wound
- Untreated osteomyelitis
- Non-enteric / unexplored fistulas
- Necrotic tissue with eschar (debride first)
- Exposed blood vessels / anastomosis
| Feature | GranuFoam (Black) | WhiteFoam (White/PVA) |
|---|---|---|
| Pore size | 400–600 μm (large) | 200–300 μm (small) |
| Granulation | Promotes faster granulation | Less aggressive ingrowth |
| Tunnels/undermining | Not ideal | Preferred (more conformable) |
| Fragile tissue | Avoid | Use (gentler) |
| Change frequency | Every 48–72h | Every 24–48h (less adherence) |
| Alarm/Problem | Likely Cause | Action |
|---|---|---|
| Leak alarm | Seal failure | Check drape edges; reinforce with additional drape strips; check tubing connections |
| Canister full alarm | High exudate | Replace canister; assess infection status if unexpectedly high |
| Blockage alarm | Clot / debris in tubing | Clamp tubing, disconnect and flush; replace if blocked |
| No therapy alarm | Power issue or canister not seated | Check power; reseat canister; check for kinked tubing |
| Pain at dressing change | Foam ingrowth | Soak with saline before removal; switch to WhiteFoam; use NPWT wound contact layer |
| Grade | Description |
|---|---|
| 0 | Pre/post-ulcerative lesion (intact skin, risk factors) |
| 1 | Superficial ulcer, no subcutaneous tissue |
| 2 | Deep ulcer to tendon, capsule or bone |
| 3 | Deep ulcer with osteitis, abscess or osteomyelitis |
| 4 | Gangrene of forefoot |
| 5 | Gangrene entire foot |
| No infection No ischaemia | Infected | Ischaemic | Both | |
|---|---|---|---|---|
| Stage 0 | 0A | 0B | 0C | 0D |
| Stage 1 | 1A | 1B | 1C | 1D |
| Stage 2 | 2A | 2B | 2C | 2D |
| Stage 3 | 3A | 3B | 3C | 3D |
D suffix = highest risk (infected + ischaemic). IWGDF 2023 uses SINBAD and WIFI for vascular surgical planning.
| Method | Gold Standard? | Notes |
|---|---|---|
| Total Contact Cast (TCC) | Gold Standard | Non-removable; best evidence for DFU healing; reduces plantar pressure 84–92% |
| Irremovable Cast Walker (iRCW) | Equivalent to TCC | Removable walker made irremovable with fiberglass tape; practical alternative |
| Removable Cast Walker (RCW) | No (compliance-dependent) | Patient compliance averaging 28% of steps; less effective but better than footwear alone |
| Custom insoles / orthotic footwear | Prevention | Post-healing prevention; pressure redistribution; 6–12 week fabrication lead time in GCC |
| Felted foam padding | Adjunct | Low cost; temporary offloading; useful in resource-limited settings |
| ABPI Value | Interpretation | Action |
|---|---|---|
| > 1.3 | Calcified vessels | ABPI unreliable; use toe pressure or TBI |
| 0.9 – 1.3 | Normal | Safe to apply full compression |
| 0.8 – 0.9 | Mild PAD | Full compression with monitoring |
| 0.6 – 0.8 | Moderate PAD | Reduced compression or refer vascular |
| < 0.6 | Severe PAD | No compression; urgent vascular referral |
- Punched-out appearance, well-defined edges
- Located at pressure points, toes, heels
- Pale/necrotic wound bed; minimal exudate
- Pain (especially at rest/night); relieved by dependency
- Cool limb, hair loss, shiny skin, absent pulses
- Recalcitrant wound not responding to antibiotics
- Slippery, mucoid film on wound surface
- Recurrence of signs of infection post-treatment
- Stalled healing despite optimal wound management
- Elevated WBC and wound inflammatory markers
- Within rectus abdominis muscle (reduces prolapse/hernia risk)
- Patient can see the site (critical for self-care)
- Away from waist/belt line (avoid pressure on appliance)
- Away from bony prominences (iliac crest, ribs, pubis)
- Away from skin folds, creases, and previous scars
- Away from umbilicus (minimum 5 cm)
- Flat surrounding area ≥ 5 cm around proposed site
| Type | Anatomy | Output | Pouching | Reversal |
|---|---|---|---|---|
| End Colostomy | Single bowel end brought to surface; distal end oversewn (Hartmann's) | Formed stool; 1–2×/day | Closed-end pouch; or irrigation | Possible if distal bowel preserved |
| Loop Colostomy | Loop of colon through abdominal wall; rod support | Formed to soft stool | Closed-end pouch | Easier reversal (elective procedure) |
| End Ileostomy | Terminal ileum; permanent (Brooke ileostomy) | Liquid-pasty; 500–1200 ml/day; corrosive | Drainable pouch; skin barrier essential | Only if bowel reconnection possible |
| Loop Ileostomy | Loop of ileum; temporary diversion for colorectal anastomosis protection | Liquid-pasty; high volume | Drainable pouch; protective barrier | Planned reversal at 8–12 weeks |
| Urostomy / Ileal Conduit | Ileal segment; ureters anastomosed; urine diverted | Continuous urine output | Urostomy pouch with tap/valve | Not reversible (usually) |
| Feature | One-Piece | Two-Piece |
|---|---|---|
| Flexibility | More flexible; lower profile | Less flexible around stoma |
| Ease of change | Single step; skin disturbed each change | Barrier stays 3–4 days; only pouch changed daily |
| Skin trauma | Higher (frequent adhesive removal) | Lower (barrier protected between changes) |
| Best for | Active patients; travel; low output | Sensitive skin; peri-stomal dermatitis |
| Profile | When to Use | Caution |
|---|---|---|
| Flat | Stoma protrudes ≥ 1.5 cm; flat abdomen; normal skin | First-line choice |
| Soft Convex | Flush stoma; slight peristomal fold | Use support belt |
| Deep Convex | Retracted stoma; deep peristomal fold | Requires hernia/belt support; risk of pressure necrosis |
- Most common complication of permanent stoma (up to 50% at 5 years)
- Prevention: early abdominal support garments post-op; stoma siting within rectus
- Support garments: high-waist peristomal support belts; Stealth Belt; Nu-Hope belts
- Pouching adaptation: flexible/convex pouches; extended-wear barriers
- Surgical repair (IPST) reserved for symptomatic cases; high recurrence rate
- Educate: avoid heavy lifting >5 kg; abdominal exercises post-healing
Successful irrigation allows patient to be "pouch-free" for 24–48h between irrigations. Takes 4–6 weeks to establish a regular pattern.
- Nutritional optimisation pre-op (BMI, albumin, prealbumin targets)
- Bowel preparation per colorectal surgeon's protocol
- Counselling on realistic expectations: bowel habit changes post-reversal common for 6–12 months
- Pelvic floor exercises pre-operatively if incontinence anticipated
- Discuss anterior resection syndrome (low anterior resection) — frequency, urgency, clustering
- Plan for potential temporary protective products during bowel re-training
- Review discharge criteria: confirm contrast enema/scope showing intact anastomosis
- Explain procedure fully; obtain written consent
- MSU (mid-stream urine) culture negative before procedure
- Discontinue anticholinergics 2 weeks prior (where safe)
- Arrive with comfortably full bladder (free flow measurement first)
- Ensure privacy; chaperone available
- Prophylactic antibiotics per protocol (especially spinal cord injury)
- Dual-lumen filling catheter (filling + vesical pressure)
- Rectal balloon catheter (abdominal pressure measurement)
- Urodynamic machine with Pdet calculation (Pdet = Pves − Pabd)
- Normal saline at body temperature for filling
- EMG electrodes if sphincter assessment needed
| Parameter | Normal Range |
|---|---|
| Maximum cystometric capacity | 300–600 ml |
| First desire to void | 150–250 ml |
| Detrusor overactivity pressure | Any rise > 0 with urgency = abnormal |
| Max flow rate (Qmax) | > 15 ml/s (female); > 12 ml/s (male) |
| Voiding detrusor pressure | < 50 cmH₂O (female); < 70 cmH₂O (male) |
| Post-void residual (PVR) | < 50 ml clinically acceptable |
| Abdominal leak point pressure | < 60 cmH₂O = intrinsic sphincter deficiency |
- Bladder diary: voids, urgency episodes, leaks before and after
- Meaningful response: ≥ 50% reduction in urgency/incontinence episodes
- Responder rate: approximately 60–75%
- Onset of response: typically 6–8 sessions
- No response after 12 sessions: consider interstim or botox
- Patient education on implant and programmer use
- Regular programming reviews (amplitude, pulse width, frequency adjustment)
- Monitor battery status — device life 3–7 years (rechargeable: 15 years)
- Symptom diary review at each visit
- Assess for lead migration (change in stimulation sensation/loss of response)
- MRI restrictions counselling (conditional approval device only — 1.5T)
| Parameter | Typical Range |
|---|---|
| Amplitude | 0.5 – 5 V (lowest effective) |
| Pulse width | 210 μs |
| Rate | 14 Hz (continuous) |
| Electrode configuration | Unipolar to bipolar; adjusted for response |
- Confirm negative urine culture (treat UTI before proceeding)
- Discontinue anticoagulants per anaesthesia protocol
- Consent: counsel on urinary retention risk (10–15%) requiring CIC
- Teach CIC technique pre-operatively if retention risk high
- Bladder preparation: minimal fluid 2–3h pre-procedure
- Monitor post-void residual at 2 and 6 weeks post-injection
- PVR > 300 ml: initiate CIC; PVR > 150 ml with symptoms: consider CIC
- UTI monitoring: urinalysis at each follow-up
- Efficacy assessment: bladder diary at 4–6 weeks
- Duration of effect: 6–9 months; repeat dosing for sustained response
- Dose: OnabotulinumtoxinA 100U (OAB); 200U (neurogenic bladder)
- Constant uncontrollable urinary leakage via vagina
- Assessment: methylene blue test (fill bladder; observe vaginal leakage)
- Cystoscopy for fistula localisation
- Catheter drainage 2–4 weeks (small fistulas may close spontaneously)
- Surgical repair: vaginal approach (Latzko); abdominal if complex
- Nursing: continent/absorptive products; skin integrity; psychological support
- Passage of flatus/stool per vaginum
- Causes: obstetric injury, Crohn's disease, radiation, post-surgical
- Assessment: barium enema or MRI fistulogram
- Low simple RVF: local repair; Crohn's RVF: medical management first
- Protecting stoma (defunctioning) may be needed pre-repair
- WOC nurse role: stoma management, skin integrity, bowel management
| Problem | Action |
|---|---|
| Bypassing (leaking around catheter) | Check for blockage; consider bladder spasm — antimuscarinic; review size |
| Unable to deflate balloon | Cut inflation valve; inject sterile water; ultrasound-guided deflation |
| Unable to insert (tract narrowed) | Use smaller catheter first; dilate tract; if failed — urgent urology |
| Haematuria | Increase fluids; if persistent or clots — cystoscopy |
| Granulation at site | Silver nitrate application; correct catheter securing angle |
- Review clinical evidence for new product submissions
- Conduct or coordinate clinical product evaluations/pilots
- Develop and maintain the institutional formulary
- Rationalise product portfolio (reduce variation, improve training)
- Negotiate with suppliers on pricing and supply reliability
- Monitor patient outcomes linked to product changes
- Stoma pouches: covered (quantity limits may apply)
- Advanced wound dressings: varies by plan; often requires pre-authorisation
- NPWT: covered in hospital; home NPWT requires specific plan
- Continence products (catheters, pads): basic plans: limited coverage
- PTNS: covered if prior-auth approved; some plans exclude
- Custom orthotics/offloading: prescription required; co-pay common
- Manufacturer donation programmes: Coloplast, Hollister, ConvaTec run compassionate supply programmes in GCC
- Hospital social work referral for financial assessment
- Zakat fund for UAE nationals in need (stoma supplies as eligible expense)
- Voluntary sector: UAE Stoma Association may assist with product access
- Generic/equivalent products: WOC nurse can identify lower-cost equivalent options
- Bulk purchasing: prescribe 3-month supply for reduced per-unit cost
- Co-investigator or study nurse in wound/stoma/continence product RCTs
- Design and conduct institutional product evaluations (pilot studies with patient cohorts)
- Collect and analyse clinical outcomes data (PUSH scores, healing trajectories)
- Present findings at WOCN conferences and in peer-reviewed publications
- Liaison with companies for early-access/compassionate supply of new technologies
- GCC opportunity: academic medical centres (Cleveland Clinic Abu Dhabi, Johns Hopkins Aramco, King Faisal) actively recruit for clinical studies
- No local WOCN training programmes in GCC currently
- CWOCN exam requires prior clinical experience + specific education programme
- High turnover: typical 2–3 year work visa cycles
- Specialty demand has grown faster than supply of credentialled nurses
- Many GCC hospitals have zero or only one CWOCN
- UAE: ~19% DM prevalence (IDF 2023 estimate); top 10 globally
- Saudi Arabia: ~18% DM prevalence; 3.4 million with DM
- Kuwait: ~23% DM prevalence — highest in region
- Qatar: ~17% DM prevalence
- DFU affects ~15–25% of DM patients in their lifetime
- GCC amputation rates remain high due to late presentation
- MDT model: diabetologist + vascular surgeon + orthopaedic surgeon + WOC nurse + podiatrist + orthotist + dietitian
- WOC nurse role: wound assessment, dressing prescription, offloading management, patient education
- Major centres: Rashid Hospital DFU clinic (Dubai), King Fahad Hospital, KFSH&RC
- Home wound care services emerging in Dubai, Abu Dhabi, Riyadh
- Telehealth wound follow-up post-COVID expansion
- A sealed, intact drainage pouch over the stoma acts as a barrier — scholars generally permit wudu to remain valid while pouch is sealed
- If pouch leaks or is open, wudu may be considered broken — patient should empty and reseal
- Patients with continuous output (ileostomy/urostomy): may follow the ruling for persons with chronic/continuous hadath — perform wudu before each prayer time
- Mini-caps or closed pouches used after irrigation may reduce this concern
- Prayer is still obligatory; stoma does not exempt from prayer
- Prostration (sujood) may require modified position if stoma pain; sitting prayer permissible if standing causes harm
- Pouch should be emptied before prayer where possible
- Deodorant drops in pouch help reduce anxiety about odour during prayer
- Ramadan and stoma: specialist fatwa permits breaking fast for medication; irrigation schedule may need adjustment
- UAE Stoma Association — patient advocacy and peer support network
- MOH UAE: stoma supply subsidy for nationals with chronic disease card
- Manufacturer patient support: Coloplast Care (UAE), Hollister Connect
- WhatsApp support groups run by local ET nurses (common in UAE)
- Saudi Stoma Association (فغرة) — patient support and awareness
- KFSH&RC has established stoma club with regular patient education events
- Qatar: HMC stoma service; Kuwait: Mubarak Hospital stoma clinic
- Online Arabic-language stoma resources growing on social media platforms
- WOCN Society Middle East chapter established and growing; annual regional conference
- Regular ET nurse study days at major UAE and Saudi hospitals
- GCC hospitals increasingly including CWOCN in nursing recruitment criteria
- UAE MOH nursing licensing: CWOCN accepted as specialist credential for upgraded pay scale
- Mentorship networks developing as longer-tenured WOC nurses support newer expatriates
- Arab nurses increasingly pursuing WOC certification (Jordan, Egypt, Lebanon as source countries)